US

Showing 15 posts of 324 posts found.

Janssen reaches partial agreement over criminal investigation

August 10, 2011
Sales and Marketing Janssen, Risperdal, US, US Justice Department, illegal

Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …

US debt deal could hit pharma

August 2, 2011
Sales and Marketing Obama, PhRMA, US, healthcare reform

The deal to raise America’s debt ceiling could have long-term consequences for the US pharma industry. The tense stand-off between …

GlaxoSmithKline OTC sale puts two plants on the block

April 19, 2011
Manufacturing and Production GSK, US, pharma manufacturing

GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …

Eisai confirms 20% cut in US workforce

March 8, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts

Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …

Merck repels jaw injury claim

February 15, 2011
Sales and Marketing Fosamax, Merck, US, lawsuit

A New Jersey state court jury has found in favour of Merck & Co in the company’s ongoing legal battle …

US healthcare ‘extreme makeover’ predicted for 2011

December 31, 2010
Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC

Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …

US prescription drug prices rise above inflation

August 27, 2010
Sales and Marketing US, prices

A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …

US court bars stem cell funding

August 26, 2010
Sales and Marketing Obama, Stem cells, US

A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …

Pfizer signs ground-breaking academic research deal

May 18, 2010
Research and Development Pfizer, US, academia, clinical research

Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …

Bayer opens US ‘science hub’

May 18, 2010
Research and Development Bayer, US, acdemia, clinical research

Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …

AstraZeneca dodges another Seroquel lawsuit

April 8, 2010
Sales and Marketing AZ, Seroquel, US

AstraZeneca has defeated another US lawsuit seeking compensation for diabetes side-effects allegedly caused by its drug Seroquel. A US Federal …

Healthcare reform momentus for pharma too

April 1, 2010
Obama, US, biosimilars, healthcare reform

Historic reforms of America’s healthcare system have now passed into law, representing its most radical overhaul ever. Nevertheless, the bill …

FDA approves Roche’s Actemra

January 11, 2010
Sales and Marketing Actemra, RoActemra, Roche, US, rheumatoid arthritis

Roche’s Actemra has been approved in the US for the treatment of moderately to severely active rheumatoid arthritis (RA) and …

Pfizer gives notice of staff cuts at former Wyeth plant

December 14, 2009
Manufacturing and Production Pfizer, US

Pfizer says it will cut around 200 staff at its Pearl River manufacturing facility in New York, US, according to …

Novartis opens $1bn flu vaccine plant

November 25, 2009
Manufacturing and Production Novartis, US, vaccines

Novartis has opened a new $1 billion vaccine manufacturing plant that is the first to be set up as a …

The Gateway to Local Adoption Series

Latest content